Posted in | News | Gold | Silver

Mercer Gold Obtains Updated NI 43-101 Technical Report on Guayabales Gold Project

Mercer Gold Corporation (OTC Bulletin Board: MRGP; Frankfurt: AN4) has received an updated technical report on the Company's Guayabales Gold Project, located in the Marmato Gold District of Colombia.

The technical report complies with National Instrument 43-101, Standards of Disclosure for Mineral Projects ("NI 43-101"), of the Canadian Securities Administrators.

"The similarities between Guayabales and Marmato are confirmed and include a number of key elements, including the same: host rocks, structural trends, styles of mineralization, and types of alteration."

"MGC has identified a bulk-tonnage, precious metals porphyry gold target. In addition, there remains significant exploration potential for higher grade gold-silver Encanto Zone mineralization..."

"...The exploration target area at Guayabales not only includes the broad lateral projection of the Marmato-Echandia trends onto the property, but as well, a potentially significant projection to depth."

Mr. Stonehouse comments, "The report is a confirmation of our exploration program to date and that we're expanding the Encanto Zone both along strike and depth with our structural drilling program.  It discusses several new targets, including the interesting Porphyry Zone and the SW zone. We are making great advances with this property that represents a property of merit, and I look forward to continued drilling and progress."

Mercer Gold also announces the resignation of Roberto Partarrieu as Director of the Company, thanks him and wishes him the best in all his future endeavours.

Source:

Mercer Gold Corporation

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.